Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Phase IIb study of XF-73 nasal gel meets primary efficacy endpoint

March 30, 2021

University of Oxford to launch a phase I study evaluating nasally administered ChAdOx1 nCoV-19

March 29, 2021

Phase I study of intranasal adenovirus vector COVID-19 vaccine candidate, BBV-154

March 29, 2021

Multiple dosing of Lassa fever candidate LHF-535 well tolerated in healthy subjects

March 26, 2021

GlaxoSmithKline initiates first-in-human study of GSK-4108771A

March 26, 2021

KM Biologics reports phase I data on tetravalent dengue vaccine KD-382

March 25, 2021

AstraZeneca reports primary analysis of U.S. phase III trial of AZD-1222

March 25, 2021

CVnCoV protects against SARS-CoV-2 B.1.351 variant in preclinical challenge study

March 24, 2021

Clover initiates phase II/III study of adjuvanted S-Trimer COVID-19 vaccine candidate

March 24, 2021

Phase II trial underway in Mali for CIS-43LS to prevent P. falciparum infection

March 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...